Neuvotion is developing breakthrough solutions for facilitating and restoring movement. Our approach combines targeted neurostimulation and AI (artificial intelligence) to deliver unparalleled therapeutic value for patients with a movement disorder or impairment from stroke or injury. Neuvotion products allow doctors and therapists to leverage state-of-the-art technology, while monitoring patient progress in-person or remotely.

 
 

The Challenge

Picture_Paralysis3.png
Picture_Stroke2.png
Picture_Injury4.png

The Market

 
Picture_Therapy_new.png

The U.S. Outpatient Rehabilitation/Physical Therapy market is more than $30 billion today and projected to grow at more than 5% per year.

(U.S. Physical Therapy, Inc.)

 

Media

 

Research Collaborators

Partner_Barrow_TR.png
Partner_GoodShepherd_TR.png
Partner_Northwell_TR.png
 

About Us

We’re an experienced team of entrepreneurs, engineers, and AI experts with a groundbreaking approach to treating paralysis and movement disorders. At Neuvotion, we believe the right team, with the right level of experience and focus, can achieve revolutionary solutions. We are devoted to our mission to help patients and are constantly seeking valuable feedback from researchers, clinicians and patients in order to learn and evolve. Contact us today to learn more.

bouton_photo.jpg

Prof. Chad Bouton

Founder and CEO

25+ years in biomedical engineering, medical device R&D, and commercialization; 70 patents; Innovator of the Year; Published in Nature

about-rory_edited.jpg

Rory Murphy, MD

Scientific Advisor

20+ years in spinal cord injury and advanced surgeries; Neurosurgeon at Barrow Neurosurgical Institute

about-travis_edited.jpg

Travis Millman, MS

COO

25+ years of innovation and startup experience. Formerly VP of New Business and Innovation at Pearson Clinical Assessment and SVP, Bus. Dev. at Audible.com.

about-sandeep.png

Sandeep Singh, MD

Scientific Advisor

25+ years in medicine

Expertise in SCI, stroke, movement disorders;

CMO, Good Shepherd Rehabilitation Services

about-trevor_edited.jpg

Trevor Hawkins, PhD

Strategy

25+ years in healthcare R&D and commercialization; Formerly with GE Ventures; Formerly Director of the Human Genome Project (DOE)

about-frank_edited.jpg

Frank Hyland, MS

Clinical Advisor

35+ years in occupational and physical therapy, Expertise in SCI, stroke, Neurorehabilitation;

VP, Good Shepherd Rehabilitation Services

 

Contact Us

Thanks for submitting!